Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WCN 2021 | Defining the etiology of dystonia

Kailash Bhatia • 30 Sep 2021
WCN 2021
Movement Disorders

Kailash Bhatia, MD, DM, FRCP, UCL Queen Square Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK, explains how to narrow down the etiology of dystonia by defining a syndrome. By identifying whether dystonia is isolated or combined with additional features such as parkinsonism or cerebellar ataxia, it is possible to narrow down the set of causes of dystonia in a patient. This interview took place during the XXV World Congress of Neurology.

More from Kailash Bhatia

Diagnosing genetic disorders: promoting equal access to advanced health centers
1:13
Diagnosing genetic disorders: promoting equal access to advanced health centers
Kailash Bhatia • 16 Sep 2022
Precision medicine: a paradigm shift in the treatment of movement disorders
2:32
Precision medicine: a paradigm shift in the treatment of movement disorders
Kailash Bhatia • 16 Sep 2022
Movement disorders diagnosis: the classic phenotypes
1:27
Movement disorders diagnosis: the classic phenotypes
Kailash Bhatia • 16 Sep 2022
Is the clinical phenomenologist obsolete in movement disorders?
2:22
Is the clinical phenomenologist obsolete in movement disorders?
Kailash Bhatia • 16 Sep 2022

Related Videos

Current treatment and unmet needs in neurologic Wilson's disease
3:15
Current treatment and unmet needs in neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Findings from the Phase III FoCus trial: tiomolibdate choline for neurologic Wilson's disease
3:18
Findings from the Phase III FoCus trial: tiomolibdate choline for neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Emerging therapies for neurologic Wilson's disease
2:42
Emerging therapies for neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Indicators of advanced-stage Parkinson’s disease
2:30
Indicators of advanced-stage Parkinson’s disease
K. Ray Chaudhuri • 30 Jun 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals